ARTICLE | Clinical News
Binosto regulatory update
March 19, 2012 7:00 AM UTC
FDA approved an NDA for Binosto alendronate from EffRx to treat osteoporosis. EffRx will launch the alendronate effervescent tablets in the U.S. in 3Q12. EffRx has exclusive, worldwide rights to IP co...